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The complement protein C8 plays a key role in the production of membrane 
damage by the  complement system. Whereas  cells which have reacted with 
seven components of complement (C1-C7)  are apparently intact with respect 
to membrane function, these cells undergo lysis after reaction with C8 (1, 2). 
Cytolysis induced by C8 is independent  of C9 and in absence of C9 proceeds 
at a slow rate, which, however, is greatly accelerated upon addition of the ter- 
minal  component  (3).  1 Accordingly,  C8  may be  regarded  as  that  protein  of 
complement  which  is  directly  responsible  for  production  of  complement- 
dependent membrane damage. 
The purpose of the present paper is three-fold: (a) A method will be described 
which permits isolation of C8, a trace protein of human serum, in highly purified 
and hemolytically active form. (b) The isolated protein will be demonstrated 
as  a  heretofore  unrecognized,  immunochemically distinct  serum  constituent 
and its molecular properties will be delineated. (c) Data will be presented show- 
ing that under optimal experimental conditions a few molecules of isolated C8 
suffice to cause lysis of a cell. 
Materials and Methods 
Serum and Purified Complement Components.--Serum  was obtained either from fresh or out- 
dated (1 month old) human blood which was purchased from the San Diego Blood Bank. Clot- 
ting was induced by addition of CaCI2  and incubation at 37  ° C for 2-3 hr, after which the blood 
was held at 4  ° C overnight. The serum was then separated by filtration through nylon gauze 
applying manual pressure to obtain maximal yield. C5 (4) and C9 (5) were prepared as de- 
scribed. 
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C8 Acti~ily Assay.--Veronal-buffered saline, pH 7.4, containing Ca  ++ and Mg++ and 0.1% 
gelatin (GVB), was used as the diluent in all hemolytic assays (6). The intermediate complex 
EAC1, 4, 2, 3, 5, 6, 7 (EAC1-7) was prepared as follows.  2 Sheep erythrocytes (E) sensitized with 
rabbit anti-sheep erythrocyte antibody (A) and carrying the first three components of comple- 
ment, EAC1, 4, 2, were prepared as described previously (7) using oxidized C2 (8). This inter- 
mediate complex was converted to EAC1-7 using a  chromatographically obtained  reagent 
containing C3, C5, C6, and C7. 
60 ml of human serum was dialyzed against phosphate buffer, pH 6, ionic strength 0.1, for24 
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Fzo. 1.  Preparation of the reagent utilized for the conversion of EACI-2 to EACI-7. Ela- 
tion profile obtained after chromatography of 60 ml of human serum on CM-ceUulose at pH 6, 
ionic strength 0.1,  in phosphate buffer. NaC1 concentration gradient was started  at fraction 
No. 50. Fractions were pooled as indicated, to include C3, C5, C6, and C7, but not C8. 
hr at 4 ° C (starting buffer)  and was applied to a 4.5 X  60 cm column of cazboxymethyl (CM)- 
cellulose which was equilibrated with starting buffer. After the column was washed with 1000 
ml of this buffer, an NaC1 concentration gradient was begun, the concentration of NaC1 in the 
limiting buffer being 1.8%. The material which emerged before the C8 activity was pooled (Fig. 
1) and immediately frozen without concentration. 
EAC  1, 4, 2 was incubated at a concentration of 5 X  108 ceils per ml with an equal volume of 
C3-7 reagent, restored to isotonicity with dextrose, and supplemented with 5-10/~g of purified 
C5 per ml of reaction mixture. After 45 rain of incubation at 37 ° C the ceils were washed at least 
three times, resuspended in GVB, and adjusted  to a  concentration of 5  X  10  s cells per ml. 
These cells could not be lysed by C9 alone, but they lysed completely within a few rain on addi- 
tion of C8 and C9. 
C8 activity was assayed with l0  s EAC1-7 cells and an excess of purified C9 in a total reac- 
tion volume of 0.6--0.8 ml. The reaction was performed at 37 ° C and stopped usually after 30 
rain by addition of 2 ml of cold saline and immediate centrifugation. 
Procedure of Isolation of C8 
Fractionation of Serum ~qth Rivanol.--Usually, 2000 ml of pooled serum served as starting 
material for one C8 preparation. The pH of the pool was adjusted to 7.5 with 1N NaOH, and 
2 Nomenclature used conforms with the recommendations of the W. H. O. Committee on 
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4 X  500 ml were filled into 1000 ml plastic containers to which an equal volume of 1% rivanol 
in water was added with constant stirring at 0 ° C. The heavy yellow-green precipitate was 
sedimented by centtifugation at 500 g for 30 rain in the cold and washed with 1000 ml of 0.5% 
rivanol  solution  in water.  Approximately  100  ml  of  a  3%  NaCI  solution  in  water  was 
then added to each container and a period of 2 hr at 4 ° C was allowed for dissolution of the 
protein precipitate. Under these conditions, most of the rivanol is insoluble and may be re- 
moved by centrifugation for 30 rain at 500 g. The protein solution was dialyzed against 2 X 
20 liters of phosphate buffer, pH 6.0, ionic strength 0.1, for 24 hr (starting buffer). 
CM-Ce)Julose Chroraatography.--Approxhnately 850 ml of packed CM-cellulose in a 4.5 X 
60 cm column was equilibrated overnight with starting buffer (see above). 400 ml of  the dia- 
lyzed rivanol fraction was applied to the column, followed by a  wash with 1000-1500 ml of 
starting buffer. The column was eluted with 3 liters of a linear NaC1 concentration gradient in 
which the limiting buffer consisted of 1.5 liter starting buffer adjusted to a conductance of 35 
m|llimhos by addition of 27 g NaC1. The flow rate was adjusted to 60 mi per hr and 15 ml frac- 
tions were collected. The C8 activity containing fractions were pooled and concentrated to 6-7 
ml by ultmfiltration using a UM10 membrane (Amlcon Corp., Cambridge, Mass.). 
Pe~ikon Block F_~ectrophore~is.--6-7 ml of the concentrated material was applied at the cen- 
ter of a 1 X  18 X  50 cm block of Pevikon in phosphate buffer, pH 6.0, ionic strength 0.05. After 
electrophoresis at 3.5 v/cm for 40 hr, the block was cut into 1,25 cm segments and eluted with 
electrophoresis buffer. The fractious containing C8 activity were pooled and concentrated to 2 
ml as described above. 
Ge~ Fi/tration.--For preparative purposes as well as for estimation of the diffusion coefficient 
of C8, a 3 X  100 cm column of Sephadex G-200 was employed which was equilibrated with the 
limiting buffer used for CM chromatography (see above). The sample volume was 2 ml, the 
flow rate was adjusted to 8-10 ml per hr and 2 ml fractions were collected. The C8 containing 
fractious were pooled and concentrated by ultraflltration to 2-3 ml. 
Absorption wi~h Insolubilized Ant~'tG-Globulin.--5  ml of a rabbit antiserum to human "yG- 
globulin was mixed with 5 ml 0.2 M acetate buffer, pH 5.2, and the protein was insolubilized by 
addition of 0.8 ml ethyl chloroformate (9). The mixture was agitated with a magnetic stirrer 
for 15 rain during which time the pH was maintained between 4.5 and 5.0 by addition of 1 N 
NaOH. After 30 mill at room temperature, the solid protein was washed 20 times with 50 ml 
portions of phosphate-buffered saline, pH 7.2. It was then washed with 5 X  50 ml 0.1% sodium 
carbonate, 10 X  50 ml 0.2 M glycine buffer, pH 2.2, and sufficient phosphate buffered saline to 
reach pH 7.2. It was finally suspended in 10 ml saline and centrifuged at 20,000 rpm for 1 hr 
in a No. 40 rotor and a Spinco L2 machine. The fluid was discarded, the walls of the tube dried 
with filter paper and the wet protein (400 nag) was suspended in 2.5 ml of C8 preparation (200-- 
600/~g/ml) after the gel filtration step. The suspension was kept overnight at 4 ° C and then 
subjected to ultracentrifugation as described above. 2.2 ml of supernatant was recovered with 
a Pasteur pipette. The extensive washing of the immune-absorbent  was necessary because ethyl 
chlomformate in a dilution of i :40,000 was found to inactivate C8 completely. 
The final product was stored in phosphate buffer, pH 6.0, ionic strength 0.1, containing 0.3 
xr NaC1 at --70  ° C after quick freezing in liquid nitrogen. 
To prevent bacterial growth during the isolation procedure, which usually lasts 12-15 days, 
all buffers used for chromatography and gel filtration contained 5 X  10  -~ ~  chloramphenicol 
and 2.5 X  10  -5 ~ kanamycine sulfate (Bristol Laboratories, Syracuse, N.Y.). 
Sucrose Density Gradient Ultracentrifugation.--Linear sucrose density gradients (7-31%) in 
phosphate buffer, pH 6.0, ionic strength 0.1, were prepared with a Buckler automatic density 
gradient device. Ultracentrifugation  was performed for 12 hr at 40,000 rpm and 4 ° C in a Spinco 
L2 centrifuge employing an SW-50 rotor. Fractions were collected with the Buchler gradient 
fractionation device. 
Analytical Polyacrylamide Gel F_Jectrophoresis.--The method described by Davis  (10) was 
used. A 5% acrylamide concentration was found to be most suitable to study the migration of 1148  EIC-KrH  COMPONENT  OF  HUMAN  COMPLEMENT  (C8) 
C8. Polymerization of the sample-containing gel and dectrophoresis were carried out at 4 ° C. 
A current of 2.5 ma per gd was applied and electrophoresis was terminated when the brom- 
phenol blue marker had traveled 5 cm from the cathodal end of the separating gel. For activity- 
protein correlation experiments, equal portions of C8 were applied simultaneously to two paral- 
lel polyacrylamide gels, one gd was subsequently stained, while the other was cut into 2.5 mm 
segments which were minced in 0.2 ml of GVB. After standing for at least 2 hr at room tempera- 
ture, the ehiates were analyzed for hemolytic activty. 
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FIG.  2. Second preparative  step of the C8 isolation  procedure:  chromatography on CM- 
cellulose  of  rivanol-precipitable  fraction  of  human serum at  pH 6,  inoic  strength  0.1,  in  phos- 
phate  buffer.  I00  g of  protein  in  400  ml  were  applied  to  the  column. The  portion  of  thc  chroma- 
togram representing  protein which was not adsorbed  (99% of the applied material) is 
not  shown. Elution  of  C8 activity  and the  adsorbed serum protein  was accomplished by  a  NaCI 
concentration  gradient.  Fractions  60-135 were  pooled  and  concentrated  for  elcctrophoresis. 
Irnmunochemical A nalyses.--Immunolo~c  analysis of the C8 preparations was performed in 
Ouchterlony plates using rabbit anfisera to C2 (11), C3 (7), C4 (12), C5 (4) and the foliownig 
antisera purchased from Behringwerke AG,  Marburg-Lahn, West Germany: anti--rG,  --~A, 
-'yM,  -/~-lipoprotein, -transferrin,  -fibrinogen,  -haptoglobin,  -a2M  and  anti whole  human 
serum. An antiserum to human C8 was prepared as described subsequently. Immunoeleetro- 
phoresis was performed according to Seheidegger (13) using either agar or ag~rose. In experi- 
ments where C8 hemolytic activity was correlated with the precipitin arc developed with an 
anti-C8 serum half of the microimmunoelectrophoresis gel was cut into 2.5 mm segments which 
were eluted with GVB for activity determination. 
C8 Protein Daermlnation.--This  was carried out with the Folin method using, arbitrarily, 
human ~?G-globulin as standard. JORGE  A.  MANNI  AND  HANS  ].  MfJLLER-EBERHARD  1149 
RESULTS 
Isolation  of CS.--Since earlier  experiments had shown that only 20% of the 
C8 activity precipitated together with the euglobulins  while 80 % remained in 
the pseudoglobulin fraction  (14),  whole serum was used as starting  material 
(140 g protein). Upon addition of rivanol,  C8 activity was precipitated together 
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FIG. 3.  Third step of C8 isolation: preparative block electrophoresis in phosphate buffer, 
pH 6.0,  ionic strength 0.05,  using Pevikon C-870 as supporting medium. 8 m] containing 800 
rng of protein and C8 activity obtained by CM chromatography were applied as indicated by 
the arrow and subjected to electrophoresis for 40 hr at a potential gradient of 3.5 v/cm. Eluates 
of segments 11-18 were pooled and concentrated for Sephadex filtration. 
FIG. 4.  Fourth step of C8 isolation: filtration on Sephadex G-200 in phosphate buffer, pH 
6.0, ionic strength 0.1, containing 0.3 M NaC1. 2 ml containing 50 mg of protein and C8 activity 
recovered from the Pevikon block were applied. Fractions containing C8 activity were com- 
bined (pool 3) and concentrated for removal of residual 3~-globulin by immune-adsorption. The 
concentrated material gave one major line on polyacrylamide gel e]ectrophores~s  as shown in 
the upper portion of the figure. For comparison, disc electrophoresis patterns of adjacent pools 
are also shown. 1150  EIGHTH  COMPONENT  OF  HUMAN  COMPLEMENT  (C8) 
with about 70 %  of the serum proteins, most of the "?-globulin and transferrin 
staying in solution. This step was desirable because ~,G-globulin proved diffi- 
cult to separate from C8 and it also resulted in a  convenient decrease in vol- 
ume. After removal of the rivanol and dialysis against starting buffer for chro- 
matography, approximately 100 g of protein in 400 ml were applied to a  CM- 
cellulose column. Washing of the column with starting buffer eliminated about 
TABLE I 
Final Purification of C8 by Absorption with Insolubilized Rabbit Anti-Human  "yG-Globulin 
Preparation No. 
Amount of protein (,.g) 
Before  After 
38  4600  1370 
40  5400  1240 
43  1220  700 
44  575  300 
TABLE  II 
Yield and Degree of Purification of C8 Isolated from  Human  Serum 
Amount of protein  No.  of effective C8 molecules 
Required for  Total  Per/~g  Total  63% lysis* 
mg  ng 
Serum  140,000  500  14  X  10  t~  1 X  l0 s 
Isolated C8 (No. 38)  1.4  0.1  7 X  1014  5  X  10 tt 
Yield  0.001%  5% 
Purification  5000 )<  5000 )< 
* 5 X  107 EAC1-7 cells. 
99%  of  the  protein  without  interfering  with  absorption  of  most  of  the  C8 
activity. The latter was eluted by NaC1 gradient as shown in Fig.  2,  and ap- 
proximately 800  mg  of protein  containing  C8  was  recovered.  This material 
was concentrated  to 8  ml and  subjected  to Pevikon block electrophoresis  at 
pH 6.0  which  resulted  in  removal of more than  90%  of non-C8 protein,  the 
latter  migrating  cathodally  and  anodally  from  the  point  of  application.  As 
shown  in  Fig.  3,  C8  activity was  recovered from segments  adjacent  to  the 
origin. The pooled fractions contained approximately 50 mg of protein which 
was passed through  a  Sephadex G-200 column. The elution  profile and poly- 
acrylamide gel electrophoresis patterns corresponding to the major peaks are 
shown in Fig.  4.  C8  activity was found  to distribute  between the  theoretical 
positions of albumin and "vG-globulin and to be associated with approximately 
5 mg of protein,  or 10% of the material applied to the column. Although  C8 JORGE A.  MANNI AND HANS J.  MfJLLER-EBERIIARD  1151 
was retarded  on Sephadex G-200 relative to the peak of "gG, the C8 pool was 
found  to be heavily contaminated  with "y-globulin when  examined  immuno- 
chemically. Instead of attempting further separation by recycling on Sephadex, 
imnmnoabsorption was introduced as final purification step in view of the rela- 
tively small amount of residual protein available. Rabbit antiserum to human 
"/G-globulin was insolubilized by treatment with ethyl chloroformate accord- 
ing to Avrameas and Ternynck (9)  and the washed, polyrnerized protein was 
used  as immune-adsorbent.  Upon absorption of the  C8 preparation after the 
Sephadex G-200 step, one-half to one-fourth of the protein was recovered (Table 
I)  and  about  75 %  of the  C8  activity.  By Ouchterlony test with  anti-human 
3,G-globulin there was no residual 3'G detectable in the absorbed C8 (Fig. 6). 
Fro. 5.  Analysis of final product of C8 isolation procedure by disc electrophoresis  and cor- 
relation between protein and C8 activity distribution. 25 #g of isolated C8 was applied to each 
of two gels. After electrophoresis, one gel was stained for protein (below) and the other was cut 
into 2.5 mm segments  for elution and localization of C8 activity (above). 
The yield of C8 activity varied between 0.25 and 5 % of the activity present 
in  serum.  Table II lists  yield  of  activity  and  of protein  for preparation  38. 
Purification  in  this  case was  calculated  to  be  5000-fold  compared to  serum. 
Using the  data of Table II and  assuming that  all  of the final product repre- 
sented active C8 protein, the total amount of C8 in 2 liters of serum was esti- 
mated to be 28 mg or 0.0002 %  of the serum protein and the concentration of 
C8  in  serum  to  be  14  #g/ml. 
Electrophoretic and Immunochemical  Examination  of Isolated  Cg.--25  /~g of 
isolated C8 was applied to each of two polyacrylamide gels and the two samples 
were  subjected  simultaneously  to  disc  electrophoresis under  identical  condi- 
tions. One gel was stained for protein, the other was analyzed for the distribu- 
tion  of  C8  hemolytic  activity.  As  illustrated  in  Fig.  5,  the  position  of  the 
activity  coincided  with  that  of  the  protein.  Additional  protein  bands  could 
not be detected. 1152  EIGHTH  COMPONENT  OF  HUMAN  COMPLEMENT  (C8) 
Fig. 6 depicts the results  of an analysis of C8 by the double diffusion-in-gel 
technique.  Gamma globulin  could not be detected  with  a  potent  rabbit  anti- 
3'G in  preparations  of C8 which had  been  subjected  to  the  final  purification 
step.  Similarly,  negative  reactions  were  obtained  with  the  following antisera 
Fro. 6.  Analysis of C8 by Ouchterlony test. Above: C8 before (step IV) and after  (step V) 
absorption with polymerized anti-3'G. Below: Comparison of isolated C8 (50 #g) with C8 in 
fresh serum and in serum stored for 1 month at 4°C. 
(not  shown):  anti-3,A,  anti-3,M,  anti-fibrinogen,  anti-transferrin,  anti-~- 
lipoprotein,  anti-a2-macroglobulin,  anti-haptoglobin,  anti-C2,  anti-C3,  anti- 
C4,  and  anti-CS.  In contrast,  a  precipitin  line  was observed  with  an  anti-C8 
which was slightly concave toward the antigen well. The anti-C8 also produced JORGE  A.  MANNI  AND  HANS  J.  M/,JLLER-EBERHARD  1153 
a  line with whole human serum which  fused with  the  C8 line,  indicating that 
anti-C8 can detect C8 in unfractionated serum. 
The  immunoelectrophoretic  appearance  of  C8  is  depicted  in  Fig.  7  which 
shows  that  the  mobility  is  dependent  on  the  type  of  supporting  gel  used. 
FIO. 7.  Immunoelectrophoretic representation of isolated C8. The upper two patterns were 
obtained using agar and the lower two using agarose as supporting medium. For reference pur- 
poses the pattern of whole human serum was included. The latter was developed with a rabbit 
anti-whole human serum, and the C8 precipitin line with a rabbit anti-human C8. The anode 
was at the right. Note that in agar C8 migrates as an a-globulin and in agarose  as  a  71-/~2 
globulin. A precipitin arc corresponding to C8 could not be seen in the pattern of whole serum. 
Fio. 8.  Comparative distribution of C8 activity and of immunochemically detectable C8 
protein after agar gel electrophoresis.  Half of the agar plate was cut into 2.5 mm segments for 
activity assay  (above)  and the other half was  developed  with an antiserum to  human C8 
(center). For comparison, the immunoelectrophoretic pattern of whole human serum is also 
shown (below). 
Whereas  in agarose  it migrates,  as in Pevikon,  like  a  fast  ~,-globulin, C8  be- 
haves in agar like an ~2-globtflin. A  similar anomalous behavior has previously 
been reported  for  isolated  C2  (11).  C8  hemolytic activity was  eluted exactly 
from the area of the gel which was occupied by the C8 precipitin arc, i.e., from 
the fast 3,-globulin position if agarose was used and from the a2 region if the 1154  EIGHTH COMPONENT OF HUMAN COMPLEMENT (C8) 
experiment  was  performed  in  agar.  The  comparative  distribution  of  the  C8 
precipitin arc and of C8 hemolytic activity in agar is shown in Fig. 8. 
Physicochemical Characterization of C8.--The  sedimentation  coefficient  of 
purified C8 was estimated by sucrose density gradient ultracentrifugation using 
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FIG. 9.  Determination  of the sedimentation  coefficient of C8 after ultracentrifugation  in a 
linear sucrose density gradient  in the presence of three reference substances  (thyroglobulin, 
19S; 3'G-globulin, 7S; hemoglobin, 4.5S). 
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FIG. 10. Elution diagram of C8 obtained after filtration on a Sephadex G-200 column (3 X 
100 cm) in the presence of three reference substances. Phosphate buffer, pH 6.0, ionic strength 
0.1, containing 0.3 M NaC1 was used. 
reference substances  with  a known s  rate.  The graphical  evaluation  of one of 
these  analyses  is  shown  in  Fig.  9.  The  diffusion  coefficient  was  determined 
using  the  same  reference  substances  by filtration  through  a  Sephadex  G-200 
column  (15).  The elution profile of C8 and  reference proteins  is illustrated  in 
Fig. 10 and the graphical analysis of this experiment in Fig. 11. It will be noted 
that although the s rate of C8 is greater than that of "yG-globulin, C8 is eluted ~ORGE  A.  MANNI  AND  HANS  7.  MI3LLER-EBERHARD  1155 
on gel filtration later than ~,G. The average values of the molecular parameters 
obtained from replicate experiments and  the calculated molecular weight  are 
listed in Table III. 
Hemolytic Efficiency of Isolated CS.--When various preparations of isolated 
C8  were  analyzed with  EAC1-7  cells for  hemolytic  activity, linear  dose  re- 
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FIG. 11.  Estimation of the diffusion coefficient of C8 after gel filtration on Sephadex G-200 
in the presence of three reference substances  (thyroglobulin,  D ~  2.5 X  10  -7 cm2/sec; TG- 
globulin, D =  3.8 X  10  -7 cm2/sec; hemoglobin, D ~  6.8 X  10  -7 cm2/sec). The elution vol- 
umes (Ve) are plotted against the reciprocal of D according to Andrews (15). 
TABLE III 
Physicochemical Properties oJ Isolated C8 
Sedimentation coefficient  8.5S 
Diffusion coefficient  5.0 X  10  -7 cm2/sec 
Molecular weight*  153,000 
Frictional rafio~  1.2 
Electrophoretic mobility§  vl 
* Assuming ~7 =  0.73. 
Determined nomographically (23). 
§ In Pevikon at pH 6.0 and 8.6. 
sponse curves were invariably obtained when the data were plotted in terms of 
the reciprocal of the negative natural logarithm of the proportion of unlysed 
cells versus the  reciprocal of the  C8  dilution. An example of a  dose response 
curve is given in Fig.  12,  which clearly demonstrates the existence of propor- 
tionality between input of C8 and the final degree of hemolysis. The prepara- 
tion used for this experiment had  a  protein concentration  of 60 #g/ml.  A  1/ 
--ln(1--y)  value of unity, which corresponds to 63 %  lysis, was obtained with 
a  44,000-fold  dilution of  this  C8  preparation.  The  actual amount  of protein 1156  EIGHTH  COMPONENT  OF  HUMAN  COMPLEMENT  (C8) 
added to 5  X  107 EAC1  7 cells at this dilution was calculated to be 227 pico- 
grams or  1.06 X  10  ~ molecules. Thus, according to the  one-hit theory of im- 
mune hemolysis (16),  21  molecules of  C8  per  cell  were  required  to  produce 
one "hemolytically effective molecule". 
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Fro. 12.  Dose response for highly purified C8: reciprocal of average number of C8 sites per 
cell [-ln(1 --y)]  versus reciprocal of C8 dilution. A[--ln(1--y)]  value of unity was obtained at 
a 44,000-fold dilution which corresponds to 227 picograms of C8 protein per 5 X 107 cells. 
TABLE IV 
Hemolytic Efficiency of C8 Expressed in Molecules Per Cell Required for 63% Hemolysis 
Preparation No.  Input  Specific uptake 
38  8  --* 
37,  38,  39  21  - 
40a  16  -- 
40b  80  -- 
40b(Z25I)  160  34 
40bl(t25I)  560  24 
43  15  -- 
*--  not done. 
Comparing various preparations with respect  to  their hemolytic efficiency, 
considerable variation was encountered. As listed in Table IV,  the number of 
C8 molecules required to produce one hemolytically detectable C8 site ranged 
from 8-560, and the hemolytic efficiency from 12-0.018%. The possibility was 
considered that  the  observed differences were  due  to  the  presence in the  C8 
preparations  of  varying  amounts  of  hemolytically inactive material.  While ~'OP~G  F.  A.  MANNI  AND  HANS  J.  M~LLER-EBF-RHARD  1157 
this possibility could not be  ruled out,  it is emphasized that  the  irnrnuno- 
electrophoretic appearance of several preparations tested was as illustrated in 
Fig. 7 and did not indicate heterogeneity. That the active and inactive forms of 
complement proteins may have a  different immunoelectrophoretic behavior 
has previously been demonstrated for C2 (11),  C3  (7),  C4 (12),  and C5 (17). 
An alternative explanation offered itself: since the data of Table IV were  ob- 
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FIG. 13. Dependence  of the apparent hemolytic  efficiency  of C8 upon the reactivity of the 
assay cells (EAC1-7). The same C8 preparation was assayed  with three different batches of 
EAC 1-7 cellswhich  differed  in the number of sites on their surface  capable of reacting  with C8. 
tained at different days with different preparations of assay cells, the encoun- 
tered variation in the hemolytic efficiency of C8 preparations might be a func- 
tion of the reactivity of the assay cells. Accordingly, several batches of EAC1-7 
cells  were prepared from EAC1,4,°xY2  using different amounts of the same 
C3,5,6,7-reagent. These cells, which were qualitatively identical but differed 
in number of C3,5,6,7 sites per cell, were reacted with the same preparation 
of C8 and the number of C8 molecules per cell required to produce 63 % lysis 
(in the presence of C9) was determined for each batch of assay cells. Fig. 13 
shows the marked dependence of the apparent hemolytic efficiency of C8 upon 1158  ~.IaHI~H  COm'ONENT  OF  ~UMAN  COM~L~.M~NT  (c8) 
the reactivity of the assay cells. It is therefore concluded that the variation in 
hemolytic efficiency encountered among different C8 preparations is, in part, 
due to variations in the functional condition of the assay cells. 
Also shown in Table IV is that only a fraction of the radiolabeled molecules 
required to achieve 63 % lysis became specifically bound to the cell surface. In 
two experiments with usI-C8,  the uptake was respectively 4.5  and  21%  of 
input.  The average of the four best input values (8, 21, 16, and 15 molecules 
per cell) is 15 C8 molecules per cell at 63 % lysis. The average uptake in the two 
experiments  with  radioactive  C8  is  12.5%.  Assuming  that  these values are 
representative for C8 under  optimal experimental  conditions,  one hemolyti- 
cally effective C8 site may be produced by 1.9 molecules of C8 protein. 
DISCUSSION 
To date, isolation and identification of the following  complement proteins 
of human serum have been reported: Clq (18),  Cls (19), C2 (11),  C3 (4),  C4 
(12), C5 (4), and C9 (3). To this group of purified proteins is now being added 
C8, the eighth component of human complement. It is an immunochemically 
definable ~l-globulin which has a calculated molecular weight of 153,000 and 
which is unrelated to either ~G, ~A, or ~M.  The protein may be obtained in 
homogeneous form as judged by polyacrylamide and ~mmunoelectrophoresis. 
Its concentration in serum is relatively low; by hemolytic activity measure- 
ments it was estimated to be 10-20 #g/ml; by a  semiquantitative  immuno- 
diffusion test it appeared to be at least twice this value. Accordingly, the yield 
of purified material  was  low and  was comparable with  that  of other  trace 
proteins of serum such as C2 (11). But unlike some other complement proteins, 
notably C2, C3, C4, and C5, ithas been found to exhibit a remarkable stability 
and resistance to "spontaneous" inactivation during  the isolation procedure. 
The presented method of isolation was elaborated during the past 3 yr and 
in its final form has been found in this laboratory to be highly reproducible. 
The use of an immune-adsorbent in the final purification step represents a de- 
parture from the exclusive use of physicochemical methods for the purification 
of other complement proteins.  It was dictated by the encountered difficulty 
to separate  C8 from a  physicochemically similar species  of vG-globulin and 
by the small amounts of protein available for final purification. It is possible 
that  recycling  on  Sephadex  G-200  or  chromatography  on  phosphoric  acid 
cation exchange cellulose might produce similar results. 
Although the yield of C8 activity in the isolated material was at best 5 % 
relative to whole serum, the degree of purification was 5000-fold. The hemolytic 
efficiency  varied  among  different  preparations  obtained,  however,  in  most 
cases it was exceedingly high  compared with other complement components 
except C1. Whereas one C1 molecule was reported to be sufficient  to produce 
one hemolytically detectable site  (20),  the number  of C2,  C3,  C4,  and  C5 IORGE  A.  MANNI  AND  HANS  J.  MOLLER-EBERt~ARD  1159 
molecules required for  the  formation d  a  hemolytic site  is  under  optimal 
conditions, respectively, 2600,  3000,  300,  and 280  (21).  Since only a  fraction 
of the molecules entering the complement reaction achieves binding to the sur- 
face of the target cell, the hemolytic efficiency of specifically cell-bound com- 
plement molecules is considerably greater than the numbers cited above. For 
C5, for example, 3-5  specifically cell-bound molecules suffice to produce one 
hemolytically effective site  (22).  The  evidence  accumulated in  the  present 
study indicates that 1-2 specifically bound C8 molecules may be equivalent to 
one  "effective  C8  molecule" in  the  sense  of Mayer's one-hit theory (16). 
The underlying calculations are predicated on the assumption that all or the 
major portion of a C8 molecule becomes cell-bound during the C8 reaction step. 
Thus,  the  complement  component,  which  is  presently  considered  directly 
responsible for the production of cell membrane damage,  approaches  in its 
specifically cell-bound form the  one molecule-one lesion relationship. 
SUMMARY 
A method was described allowing the isolation of the eighth component d 
complement, C8, from human serum.  C8 is an immunochemically definable, 
heretofore unrecognized serum protein with  a  molecular weight d  approxi- 
mately 150,000 and an electrophoretic mobility of a -}q-globulin. It may be ob- 
tained with 5 % yield as a 5000-fold purified, physicochemicaUy and immuno- 
chemically homogeneous protein.  Under optimal experimental conditions,  a 
few molecules of C8 were found sufficient for lysis of a ceil. 
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